Ovarian cancer is an aggressive disease that is frequently detected at advanced stages and
is initially very responsive to platinum-based chemotherapy. However, the majority of …

Ovarian carcinoma is characterized by heterogeneity at the molecular, cellular and
anatomical levels, both spatially and temporally. This heterogeneity affects response to …

Ovarian cancer is the third most common gynecologic malignancy worldwide but accounts
for the highest mortality rate among these cancers. A stepwise approach to assessment …

Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the
United States and is the country's fifth most common cause of cancer mortality in women. A …

The development of guidelines is one of the core activities of the European Society for
Medical Oncology (ESMO) and European Society of Gynaecologial Oncology (ESGO), as …

Epithelial ovarian cancer generally presents at an advanced stage and is the most common
cause of gynaecological cancer death. Treatment requires expert multidisciplinary care …

Financial Disclosure Ernst Lengyel disclosed that money was paid to his institution from
AbbVie (funding preclinical studies), NCI (RO1 grants), and the Ovarian Cancer Research …

Background Treatment of newly diagnosed advanced-stage ovarian cancer typically
involves cytoreductive surgery and systemic chemotherapy. We conducted a trial to …

PURPOSE We report the final, protocol-specified analysis of overall survival (OS) in GOG-
0218, a phase III, randomized trial of bevacizumab in women with newly diagnosed ovarian …

Assessment of the immune response to tumors is growing in importance as the prognostic
implications of this response are increasingly recognized, and as immunotherapies are …